Mirza et al. [21], in a cross-sectional study including two community-based cohorts (964 and 946 subjects) of elderly whites, investigated the relationships between serum iFGF23 levels and different markers of obesity and insulin utilization. The gene discussed is INS; the disease is obesity disorder.